Tang, Wenting
Shao, Qiong
He, Zhanwen
Zhang, Xu
Li, Xiaojuan
Wu, Ruohao
Funding for this research was provided by:
National Natural Science Foundation of China (81800155)
Article History
Received: 10 January 2023
Accepted: 29 March 2023
First Online: 3 April 2023
Declarations
:
: The authors declare that they have no conflicts of interest.
: All procedures for the kidney renal clear cell carcinoma (KIRC) validation cohort were done in agreement with the Declaration of Helsinki and approved by the Ethical Committee of the Sun Yat-sen Cancer Center (Approval Number: B2022-472-01). Due to the retrospective study design, the Ethical Committee of the Sun Yat-sen Cancer Center approved a waiver of written informed consent to use the KIRC tumor specimens.
: Not applicable.